Literature DB >> 22963118

Elderly Chinese and their family caregivers' perceptions of good care: a qualitative study in Shandong, China.

Lydia W Li1, Yan Long, Elizabeth Lehr Essex, Yujie Sui, Lingzui Gao.   

Abstract

This study aims to understand what older Chinese people with chronic illness and their family caregivers perceive to be good care, and to compare perspectives of those living in rural and urban areas. We conducted semistructured interviews with 24 care recipients and 23 caregivers in Shandong, China. Two major themes were identified: (a) filial piety as the standard, and (b) modifying cultural ideals to meet reality. There was overall consistency in perceptions of study participants. Variations between rural and urban elders' perceptions appear to reflect differences in socioeconomic development and institutional structures.

Entities:  

Mesh:

Year:  2012        PMID: 22963118     DOI: 10.1080/01634372.2012.703165

Source DB:  PubMed          Journal:  J Gerontol Soc Work        ISSN: 0163-4372


  4 in total

1.  Cross-cultural comparison of successful aging definitions between Chinese and Hmong elders in the United States.

Authors:  Annie L Nguyen; David W Seal
Journal:  J Cross Cult Gerontol       Date:  2014-06

2.  Empirical Research on Male Preference in China: A Result of Gender Imbalance in the Seventh Population Census.

Authors:  Yanzhe Zhang; Bowen Zou; Huai Zhang; Jian Zhang
Journal:  Int J Environ Res Public Health       Date:  2022-05-26       Impact factor: 4.614

3.  Physical multimorbidity and lifetime suicidal ideation and plans among rural older adults: the mediating role of psychological distress.

Authors:  Zhengyue Jing; Jie Li; Pei Pei Fu; Yi Wang; Yemin Yuan; Dan Zhao; Wenting Hao; Caiting Yu; Chengchao Zhou
Journal:  BMC Psychiatry       Date:  2021-02-06       Impact factor: 3.630

4.  Authoritative Parents and Dominant Children as the Center of Communication for Sustainable Healthy Aging.

Authors:  Elizabeth Wianto; Elty Sarvia; Chien-Hsu Chen
Journal:  Int J Environ Res Public Health       Date:  2021-03-22       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.